Navigation Links
Frost & Sullivan Lauds Aesku.Diagnostics For Providing an Overall Analysis Platform For a Wide Range of Autoimmune Complications

LONDON, March 3 /PRNewswire/ -- Based on its recent analysis of the autoimmune disease diagnostics markets, Frost & Sullivan recognizes Aesku.Diagnostics with the 2008 European Frost & Sullivan Product Line Strategy Award for its consistent approach towards product development. It has anticipated and catered to the needs in bio-marker identification, offered versatile immunoassay systems, extended research capabilities as well as delivered unprecedented sensitivity and exceptional performance.


In just eight years of its existence, Aesku.Diagnostics has acquired several antigen and therapy patents and has become a recognised name in the autoimmune diagnostics market in more than 80 countries. It has earned a solid reputation in the market for launching over 140 different products, catering to autoimmune diagnostics and laying equal emphasis on all the major disease sectors under the autoimmune disease diagnostic space.

"Its products fall under two major brands namely, AESKULISA(R) {enzyme-linked immunosorbent assays (ELISA) kits} and AESKUSLIDES(R) (immunofluorescence slide panels)," says Frost & Sullivan Suraj Ramanathan. "The AESKU tests are developed based on human recombinant antigens or native antigens (conformational epitopes) depending on the optimal clinical correlation."

ELISA kits are more popular for autoimmune diagnosis; the company provides more than 100 CE marked kits incorporating human recombinant antigens synthesized in-house to assure maximum sensitivity and specificity. The kits can be used for diagnosing rheumatology, thrombosis, gastroenterology, vasculitis, thyroid, diabetes, hepatology and other rare autoimmune complications. While its 30-30-30 test format can be used with most commercially available automated test platforms, its special in-house plate coating and production facility offers a shelf life of up to 24 months with a production capacity of nearly 500 plates per hour.

The AESKUSLIDES(R) brand encompasses a broad portfolio of immunofluorescence slides. All these slides are vacuum-sealed for longer shelf life as well as stability, and use a highly hydrophobic Teflon mask to avoid sample cross contamination.

Such innovations point to a strong focus on research. Aesku.Diagnostics is looking to centralise its research and production to provide a universal protocol compatible with both automated and manual handling of assays. This development methodology, known as the 'ONE' Aesku concept, includes one working protocol, one pre-dilution ratio, one buffer system, one reagent system, one calibration range, one cut-off and one assay platform for all available Aesku tests.

"The 'ONE' clearly improves the lab throughput and reduces the diagnosis time," notes Suraj Ramanathan. "Furthermore, the company has always adhered to providing customers with uninterrupted services and implementing novel strategies such as 'second opinion lab service', which aid customers with queries regarding sample diagnosis on a complementary basis."

Aesku.Diagnostics has also noted the necessity of automation in the autoimmunity lab, considering a tender is incomplete if the manufacturer/distributor does not offer automation of the tests. To address this need, it has developed HELMED(R), an automatic flexible processor capable of running and managing routine tests for autoimmunity and infectious serology within the laboratory.

The HELMED(R) project, together with the already implemented Aesku 'ONE; concept (the same reagent system and protocol being shared by the complete reagent panel), will give the company the tools and arguments to consolidate sales in mature markets," observes Ramanathan. "It will also increase market shares in the developing markets and have full control of the automation key, so important for the future of the business."

Each year, Frost & Sullivan presents this award to the company that has demonstrated the most insight into customer needs and product demands. The recipient company should have optimized its product line by leveraging products with the various price, performance, and feature points required by the market.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.


Aesku.Diagnostics, based in Wendelsheim, Germany, is a research-focused supplier of innovative and efficient products and services for the early detection, diagnosis and prognosis of autoimmune diseases. In only nine years since its foundation Aesku has become a recognized name in the autoimmune diagnostics market for launching over 140 different products clearly improving the lab throughput together with uninterrupted services in more than 80 countries worldwide. With Aesku.Systems (Lab automation) and Aesku.Therapy (Autoimmune Therapies) the company diversifies its portfolio consistently to meet upcoming needs in the autoimmune diseases sector. For more information about the Aesku group please visit

    Hugo Ribeiro, International Sales Manager AESKU.DIAGNOSTICS,, P: 0049 (0) 6734.9627.0, Fax: 0049 (0) 6734.9627.27

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership(TM) empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnership Services, visit

    Ciara Jamie Connolly | Senior Events & Promotions Executive, EMEA, Best
    Practices, Frost & Sullivan,, P: 0044 (0)
    207.915.7868, F: 0044 (0) 207.730.3343,

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Frost & Sullivan Lauds Veran Medical for its IG4 Plug-n-Play Navigation System
2. Frost & Sullivan Says, Rising Awareness Boosts High Acuity Areas Monitoring Systems Market in Eastern Europe
3. Frost & Sullivan Awards to Celebrate Healthcare Excellence
4. Market for Niche Blockbusters Promises an Attractive Future for Large Pharmaceutical Companies, Indicates Frost & Sullivan
5. Frost & Sullivan: The Brazilian Municipal Water and Wastewater Treatment Market Set to Double Within the Next Seven Years
6. Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention
7. Frost & Sullivan Recognizes WCC for Its Unique Multimodal Platform
8. Frost & Sullivan Recognizes Horphags Pioneering R&D Efforts in Health Ingredients
9. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
10. Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation
11. Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search ... one of Joplin's most famous and beautiful concert posters. The concert was held on ... Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom was ...
(Date:11/26/2015)... Las Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... holiday shopping strategy. Many customers choose to buy during the Black Friday and ... holiday gifts. Shoppers don’t need to search the Internet high and low to find ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... 26, 2015 , ... WorldCare International, Inc., the first company ... Employee Benefits Conference. The Employee Benefits Conference was hosted by the International Foundation ... 11th, 2015. The conference was held at the Hawaii Convention Center in Honolulu, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 27, 2015 --> ... go online. The potential to save costs, improve treatment ... far from fully exploited as yet. Here, particular emphasis ... either via mobile tablet or directly at the patients, ... ) -->      (Photo: ...
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
Breaking Medicine Technology: